HCV-TARGET

HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network- A Longitudinal, Observational Study

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Trial Website: https://clinicaltrials.gov/show/NCT01474811

Are you Eligible? (Inclusion Criteria)

Inclusion Criteria:

  • All adult patients (age 18 or older) being treated with antiviral HCV treatment regimens that contain telaprevir or boceprevir.

Exclusion Criteria:

  • Inability to provide written informed consent.
  • Currently participating in another clinical trial of hepatitis C therapeutics. Studies comparing HCV RNA assays are not considered exclusionary.

Specialty Area(s)

Trial Location

NYP/Columbia
New York, NY 10032
United States